These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31059547)

  • 1. Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems.
    Bailly L; David R; Chevrier R; Grebet J; Moncada M; Fuch A; Sciortino V; Robert P; Pradier C
    PLoS One; 2019; 14(5):e0216221. PubMed ID: 31059547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).
    Tifratene K; Duff FL; Pradier C; Quetel J; Lafay P; Schück S; Benzenine E; Quantin C; Robert P
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):1005-12. PubMed ID: 22718684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of Drugs for Alzheimer's Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA).
    Herr M; Ankri J; Diard C; Hiance-Delahaye A
    Drugs Aging; 2021 Jan; 38(1):63-74. PubMed ID: 33410119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system.
    Le Duff F; Develay AE; Quetel J; Lafay P; Schück S; Pradier C; Robert P;
    J Alzheimers Dis; 2012; 29(4):891-902. PubMed ID: 22366771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008.
    Bailly L; Giusiano B; Barjoan EM; Michiels JF; Ambrosetti D; Lacombe S; Granon C; Viot A; Dunais B; Daurès JP; Pradier C
    Cancer Epidemiol; 2011 Dec; 35(6):e62-8. PubMed ID: 21852219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    Pivot D; Debouverie M; Grzebyk M; Brassat D; Clanet M; Clavelou P; Confavreux C; Edan G; Leray E; Moreau T; Vukusic S; Hédelin G; Guillemin F
    PLoS One; 2016; 11(12):e0167556. PubMed ID: 27936086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mini mental state examination at the time of Alzheimer's disease and related disorders diagnosis, according to age, education, gender and place of residence: a cross-sectional study among the French National Alzheimer database.
    Pradier C; Sakarovitch C; Le Duff F; Layese R; Metelkina A; Anthony S; Tifratene K; Robert P
    PLoS One; 2014; 9(8):e103630. PubMed ID: 25093735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian estimation of a cancer population by capture-recapture with individual capture heterogeneity and small sample.
    Bailly L; Daurès JP; Dunais B; Pradier C
    BMC Med Res Methodol; 2015 Apr; 15():39. PubMed ID: 25902941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records.
    Nedelec T; Couvy-Duchesne B; Monnet F; Daly T; Ansart M; Gantzer L; Lekens B; Epelbaum S; Dufouil C; Durrleman S
    Lancet Digit Health; 2022 Mar; 4(3):e169-e178. PubMed ID: 35216751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.
    Norton S; Matthews FE; Barnes DE; Yaffe K; Brayne C
    Lancet Neurol; 2014 Aug; 13(8):788-94. PubMed ID: 25030513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the prevalence of depression associated with healthcare use in France using administrative databases.
    Filipovic-Pierucci A; Samson S; Fagot JP; Fagot-Campagna A
    BMC Psychiatry; 2017 Jan; 17(1):1. PubMed ID: 28049496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The French National Alzheimer database: a fast growing database for researchers and clinicians.
    Anthony S; Pradier C; Chevrier R; Festraëts J; Tifratene K; Robert P
    Dement Geriatr Cogn Disord; 2014; 38(5-6):271-80. PubMed ID: 24994018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of neurodegenerative diseases in administrative databases in France: A systematic review of the literature].
    Gallini A; Moisan F; Maura G; Carcaillon-Bentata L; Leray E; Haesebaert J; Bruandet A; Moutengou E; Luciano L; Weill A; Marin B; Gardette V
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S183-S197. PubMed ID: 28341166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).
    David R; Manera V; Fabre R; Pradier C; Robert P; Tifratene K
    J Alzheimers Dis; 2016 Jul; 53(4):1365-73. PubMed ID: 27392860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis.
    Niu H; Álvarez-Álvarez I; Guillén-Grima F; Aguinaga-Ontoso I
    Neurologia; 2017 Oct; 32(8):523-532. PubMed ID: 27130306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic variations of multiple sclerosis in France.
    Fromont A; Binquet C; Sauleau EA; Fournel I; Bellisario A; Adnet J; Weill A; Vukusic S; Confavreux C; Debouverie M; Clerc L; Bonithon-Kopp C; Moreau T
    Brain; 2010 Jul; 133(Pt 7):1889-99. PubMed ID: 20551111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
    Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
    NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the French National Health Insurance Information System as a tool for epidemiological surveillance of malaria.
    Delon F; Mayet A; Thellier M; Kendjo E; Michel R; Ollivier L; Chatellier G; Desjeux G
    J Am Med Inform Assoc; 2017 May; 24(3):588-595. PubMed ID: 28040684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antipsychotics is associated with lower mortality in patients with Alzheimer's disease: A nationwide population-based nested case-control study in Taiwan.
    Chu CS; Li WR; Huang KL; Su PY; Lin CH; Lan TH
    J Psychopharmacol; 2018 Nov; 32(11):1182-1190. PubMed ID: 29926765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.